Loading...
Loading...
Browse all stories on DeepNewz
VisitPrediction Markets
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
IL4RxIL31 receives FDA approval by end of 2025? | Binary | 5 | 7 months ago | ||
IL4RxIL31 advances to next clinical trial phase by mid-2025? | Binary | 5 | 7 months ago | ||
IL4RxIL31 development discontinued by end of 2025? | Binary | 5 | 7 months ago | ||
Market response to IL4RxIL31 trial results announcement | Categorical | 5 | 7 months ago | ||
Comparative effectiveness of IL4RxIL31 by end of 2025 | Categorical | 5 | 7 months ago | ||
Impact of IL4RxIL31 on J&J's immunology revenue by end of 2026 | Categorical | 5 | 7 months ago |